A detailed history of Walleye Capital LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 108,968 shares of HOWL stock, worth $171,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,968
Previous 98,440 10.69%
Holding current value
$171,079
Previous $240,000 3.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.71 - $2.95 $18,002 - $31,057
10,528 Added 10.69%
108,968 $231,000
Q2 2024

Aug 14, 2024

BUY
$2.34 - $6.75 $230,349 - $664,470
98,440 New
98,440 $240,000

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $46.4M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.